AN2 Therapeutics annual current ratio
2021
2022
2023
2024
2025
AN2 Therapeutics Current Ratio Growth & History (ANTX)
AN2 Therapeutics's current ratio was 6.87 for fiscal 2025.
View full AN2 Therapeutics company overviewAN2 Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 6.87 | −1.55 | −18.42% |
| 2024 | 2024-12-31 | 8.43 | 0.56 | +7.07% |
| 2023 | 2023-12-31 | 7.87 | −5.85 | −42.66% |
| 2022 | 2022-12-31 | 13.72 | −3.98 | −22.48% |
| 2021 | 2021-12-31 | 17.70 | — | — |
AN2 Therapeutics quarterly current ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 14.32 | 4.65 | +48.12% |
| Q1 2026 | 2026-03-31 | 15.73 | 7.05 | +81.23% |
| Q4 2025 | 2025-12-31 | 6.87 | −1.55 | −18.42% |
| Q3 2025 | 2025-09-30 | 9.33 | −0.42 | −4.28% |
| Q2 2025 | 2025-06-30 | 9.67 | — | — |
| Q1 2025 | 2025-03-31 | 8.68 | — | — |
| Q4 2024 | 2024-12-31 | 8.43 | 0.56 | +7.07% |
| Q3 2024 | 2024-09-30 | 9.75 | 1.23 | +14.48% |
| Q4 2023 | 2023-12-31 | 7.87 | −5.85 | −42.66% |
| Q3 2023 | 2023-09-30 | 8.52 | −15.69 | −64.81% |
| Q2 2023 | 2023-06-30 | 8.80 | −19.37 | −68.76% |
| Q1 2023 | 2023-03-31 | 10.54 | −13.00 | −55.22% |
| Q4 2022 | 2022-12-31 | 13.72 | −3.98 | −22.48% |
| Q3 2022 | 2022-09-30 | 24.21 | — | — |
| Q2 2022 | 2022-06-30 | 28.17 | — | — |
| Q1 2022 | 2022-03-31 | 23.55 | — | — |
| Q4 2021 | 2021-12-31 | 17.70 | — | — |
AN2 Therapeutics current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, AN2 Therapeutics's current ratio decreased from 17.70 to 6.87, a change of −10.83. The latest reported quarter, Q2 2026, shows 14.32.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AN2 Therapeutics source filings ↗